COVID vaccine weekly: can the UK vaccinate 15 million people by mid-February?

As vaccine programmes gather pace worldwide, attention continues to focus on both viral mutations and the Oxford/AstraZeneca vaccine – sometimes simultaneously. South Africa has temporarily halted the vaccine’s rollout. This is because a preliminary study (yet to be released or reviewed by other scientists) suggests that the vaccine provides limitedContinue Reading